United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - linezolid - oral tablet - 600mg

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; sodium starch glycollate type a; hyprolose; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - linezolid cip is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid cip is active against gram-positive bacteria only.,linezolid cip has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: maize starch; hyprolose; sodium starch glycollate type a; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000 - linezolid cip is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid cip is active against gram-positive bacteria only.,linezolid cip has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: citric acid; sodium hydroxide; sodium citrate dihydrate; water for injections; hydrochloric acid; glucose monohydrate - linezolid sz is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics,including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: citric acid; sodium hydroxide; sodium citrate dihydrate; water for injections; hydrochloric acid; glucose monohydrate - linezolid sandoz is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics,including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium dihydrogen citrate; sodium starch glycollate; povidone; magnesium stearate; titanium dioxide; hypromellose; peg-40 stearate - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: citric acid; glucose monohydrate; sodium hydroxide; hydrochloric acid; water for injections; sodium citrate dihydrate - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: povidone; sodium dihydrogen citrate; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; titanium dioxide; hypromellose; peg-40 stearate - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: citric acid; glucose monohydrate; sodium hydroxide; hydrochloric acid; water for injections; sodium citrate dihydrate - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

steriscience pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: citric acid; glucose monohydrate; sodium hydroxide; hydrochloric acid; water for injections; sodium citrate dihydrate - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.